Imugene Ltd
ASX:IMU
Imugene Ltd
ASX:IMU
Price:
0.072 AUD
1.41%
Market Closed
Updated:
May 19, 2024
Imugene Ltd
Interest Income Expense
|
Imugene Ltd
Interest Income Expense Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Imugene Ltd
ASX:IMU
|
Interest Income Expense
AU$3.7m
|
CAGR 3-Years
136%
|
CAGR 5-Years
268%
|
CAGR 10-Years
31%
|
|
|
Immutep Ltd
ASX:IMM
|
Interest Income Expense
AU$2.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Interest Income Expense
-$18.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Interest Income Expense
-$469m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-25%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Interest Income Expense
-AU$3.5m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-40%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Interest Income Expense
-AU$733k
|
CAGR 3-Years
60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Imugene Ltd's Interest Income Expense?
Interest Income Expense
3.7m
AUD
3.7m
AUD
Based on the financial report for Dec 31, 2023, Imugene Ltd's Interest Income Expense amounts to 3.7m AUD.
What is Imugene Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
31%
31%
Over the last year, the Interest Income Expense growth was 1 992%. The average annual Interest Income Expense growth rates for Imugene Ltd have been 136% over the past three years , 268% over the past five years , and 31% over the past ten years .
You don't have any saved screeners yet
